Three-year audiological outcomes of the latest generation middle ear transducer (MET) implant.

Henryk Skarzynski Beata Dziendziel Elżbieta A Włodarczyk Piotr Henryk Skarzynski

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2020)

Despite changes in the transducer implemented by the manufacturer, we observed a significant number of adverse events in users of the latest generation of MET.

Keyphrases

tyrosine kinase
soft tissue
insulin resistance
weight loss